Catherine Tralau-Stewart
Technik-/Wissenschafts-/F&E-Leiter bei VALIRX PLC
Profil
Catherine Jane Tralau-Stewart is currently the Chief Scientific Officer at ValiRx Plc and a Member of the British Pharmacological Society.
She was previously the Chief Scientific Officer at C4X Discovery Holdings Plc.
Tralau-Stewart received her undergraduate and doctorate degrees from UCL Medical School.
Aktive Positionen von Catherine Tralau-Stewart
| Unternehmen | Position | Beginn |
|---|---|---|
| VALIRX PLC | Technik-/Wissenschafts-/F&E-Leiter | 08.09.2022 |
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Catherine Tralau-Stewart
| Unternehmen | Position | Ende |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 10.01.2023 |
Ausbildung von Catherine Tralau-Stewart
| UCL Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| VALIRX PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
